EGFR and KRAS mutations and altered c-Met gene copy numbers in primary non-small cell lung cancer and associated stage N2 lymph node-metastasis

被引：30

作者：

Han, Cheng-Bo ^{[1
]}

Ma, Jie-Tao ^{[1
]}

Li, Fan ^{[2
]}

Zhao, Jian-Zhu ^{[1
]}

Jing, Wei ^{[1
]}

Zhou, Yang ^{[1
]}

Zou, Hua-Wei ^{[1
]}

机构：

[1] China Med Univ, Shengjing Hosp, Dept Oncol 1, Shenyang 110022, Peoples R China

[2] China Med Univ, Coll Basic Sci, Shenyang 110001, Peoples R China

来源：

CANCER LETTERS | 2012年 / 314卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Non-small cell lung cancer; Epidermal growth factor receptor; KRAS; MET; Mutation; Gene copy number; TYROSINE KINASE INHIBITORS; CLINICAL-IMPLICATIONS; ACQUIRED-RESISTANCE; PRIMARY TUMORS; GEFITINIB; HETEROGENEITY; AMPLIFICATION; EXPRESSION; BIOMARKERS;

D O I：

10.1016/j.canlet.2011.09.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This study aimed to detect mutations in EGFR and KRAS and alterations of c-Met gene copy number (GCN) changes in primary and lymph node-metastatic NSCLCs. The data showed the concordant rate of EGFR genotype in primary and stage N2 lymph node-metastatic tumors was 95.45%. c-Met GCN in stage N2 lymph nodes was significantly higher than that of the primary tumors (P = 0.038). The results suggest both primary and lymph-node metastases have relatively consistent EGFR mutations and EGFR mutations are not relevant to changes in c-Met GCN. c-Met GCN was increased significantly in EGFR TKI-naive patients with lymph node-metastatic tumors. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

引用

页码：63 / 72

页数：10

共 33 条

[1] Phenotype of bone metastases of non-small cell lung cancer:: Epidermal growth factor receptor expression and K-RAS mutational status [J].

Badalian, Gayane ;

Barbai, Tamas ;

Raso, Erzsebet ;

Derecskei, Katalin ;

Szendroi, Miklos ;

Timar, Jozsef .

PATHOLOGY & ONCOLOGY RESEARCH, 2007, 13 (02) :99-104

[2] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib [J].

Bean, James ;

Brennan, Cameron ;

Shih, Jin-Yuan ;

Riely, Gregory ;

Viale, Agnes ;

Wang, Lu ;

Chitale, Dhananjay ;

Motoi, Noriko ;

Szoke, Janos ;

Broderick, Stephen ;

Balak, Marissa ;

Chang, Wen-Cheng ;

Yu, Chong-Jen ;

Gazdar, Adi ;

Pass, Harvey ;

Rusch, Valerie ;

Gerald, William ;

Huang, Shiu-Feng ;

Yang, Pan-Chyr ;

Miller, Vincent ;

Ladany, Marc ;

Yang, Chih-Hsin ;

Pao, William .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20932-20937

[3] Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients [J].

Cappuzzo, Federico ;

Marchetti, Antonio ;

Skokan, Margaret ;

Rossi, Elisa ;

Gajapathy, Sujatha ;

Felicioni, Lara ;

del Grammastro, Maela ;

Sciarrotta, Maria Grazia ;

Buttitta, Fiamma ;

Incarbone, Matteo ;

Toschi, Luca ;

Finocchiaro, Giovanna ;

Destro, Annarita ;

Terracciano, Luigi ;

Roncalli, Massimo ;

Alloisio, Marco ;

Santoro, Armando ;

Varella-Garcia, Marileila .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) :1667-1674

[4] KRAS Mutation Status in Primary Nonsmall Cell Lung Cancer and Matched Metastases [J].

Cortot, Alexis B. ;

Italiano, Antoine ;

Burel-Vandenbos, Fanny ;

Martel-Planche, Ghyslaine ;

Hainaut, Pierre .

CANCER, 2010, 116 (11) :2682-2687

[5] Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer [J].

Daniele, Lorenzo ;

Cassoni, Paola ;

Bacillo, Elisa ;

Cappia, Susanna ;

Righi, Luisella ;

Volante, Marco ;

Tondat, Fabrizio ;

Inghirami, Giorgio ;

Sapino, Anna ;

Scagliotti, Giorgio V. ;

Papotti, Mauro ;

Novello, Silvia .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) :684-688

[6] MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling [J].

Engelman, Jeffrey A. ;

Zejnullahu, Kreshnik ;

Mitsudomi, Tetsuya ;

Song, Youngchul ;

Hyland, Courtney ;

Park, Joon Oh ;

Lindeman, Neal ;

Gale, Christopher-Michael ;

Zhao, Xiaojun ;

Christensen, James ;

Kosaka, Takayuki ;

Holmes, Alison J. ;

Rogers, Andrew M. ;

Cappuzzo, Federico ;

Mok, Tony ;

Lee, Charles ;

Johnson, Bruce E. ;

Cantley, Lewis C. ;

Janne, Pasi A. .

SCIENCE, 2007, 316 (5827) :1039-1043

[7] High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH [J].

Garnis, C ;

Lockwood, WW ;

Vucic, E ;

Ge, Y ;

Girard, L ;

Minna, JD ;

Gazdar, AF ;

Lam, S ;

MacAulay, C ;

Lam, WL .

INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (06) :1556-1564

[8] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors [J].

Gazdar, A. F. .

ONCOGENE, 2009, 28 :S24-S31

[9] Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites [J].

Gomez-Roca, Carlos ;

Raynaud, Christophe M. ;

Penault-Llorca, Frederique ;

Mercier, Olaf ;

Commo, Frederic ;

Morat, Luc ;

Sabatier, Laure ;

Dartevelle, Philipe ;

Taranchon, Estelle ;

Besse, Benjamin ;

Validire, Pierre ;

Italiano, Antoine ;

Soria, Jean-Charles .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (10) :1212-1220

[10] Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer [J].

Gow, C. -H. ;

Chang, Y. -L. ;

Hsu, Y. -C. ;

Tsai, M. -F. ;

Wu, C. -T. ;

Yu, C. -J. ;

Yang, C. -H. ;

Lee, Y. -C. ;

Yang, P. -C. ;

Shih, J. -Y. .

ANNALS OF ONCOLOGY, 2009, 20 (04) :696-702

← 1 2 3 4 →